Milbemycin Oxime/Lufenuron
84 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
84
Total Reports
3
Deaths Reported
360.0%
Death Rate
Active Ingredients
Milbemycin Oxime/Lufenuron
Administration Routes
OralUnknown
Species Affected
Dog 84
Most Affected Breeds
Retriever - Labrador 13
Crossbred Canine/dog 6
Greyhound 6
Chihuahua 5
Shepherd Dog - German 5
Pit Bull 5
Dog (unknown) 5
Shih Tzu 4
Retriever - Golden 4
Schnauzer - Miniature 3
Most Reported Reactions
Vomiting 19
Lethargy (see also Central nervous system depression in 'Neurological') 13
Diarrhoea 12
INEFFECTIVE, HOOKS 8
Other abnormal test result NOS 6
INEFFECTIVE, HEARTWORM LARVAE 6
Decreased appetite 5
Lack of efficacy (endoparasite) - tapeworm 5
Emesis (multiple) 5
Anorexia 5
Behavioural disorder NOS 4
Underdose 4
Outcome Breakdown
Outcome Unknown
45 (53.6%)
Recovered/Normal
29 (34.5%)
Ongoing
5 (6.0%)
Euthanized
2 (2.4%)
Recovered with Sequela
2 (2.4%)
Died
1 (1.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.